Found 156 matching trials
A Combination of Acalabrutinib With R-CHOP for Patient Diffuse Large B-cell Lymphoma (DLBCL) PHASE1 Previously untreated CD20 positive diffuse large B-cell lymphoma (DLBCL) re...
Show More Location
Southampton University Hospitals NHS Tust
Learn More & Join Trial
High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma PHASE2 A prospective pilot trial was proposed to patients with DLBCL, with IH or h...
Show More Location
University Hospital
Learn More & Join Trial
Go-CHOP as the Frontline Therapy for PTCL PHASE2 This is a phase 2 Study to investigate the safety, tolerability, and anti-t...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) PHASE2 This study is a prospective, open-label, multicenter study in previously un...
Show More Location
The Affiliated Hospital of Xuzhou Medical University
Learn More & Join Trial
Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma PHASE2 About 60% of patients with DLBCL can be cured with a chemotherapy program. ...
Show More Location
Memorial Sloan Kettering Cancer Center
Treatments Being Tested
Etoposide, carboplatin, ifosfamide Rituximab, Ifosfamide, Etoposide, Carboplatin Rituximab, Ifosfamide, Etoposide, Carboplatin, Stem Cell Collection, Mitoxantrone, Cyclophosphamide and etoposide, Carmustine Learn More & Join Trial
The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma NA 270 untreated patients, age between 18 and 65 years , with diffuse large B-...
Show More Location
Fourth Hospital of Hebei Medical University
Learn More & Join Trial
Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1 N/A The primary objective is to evaluate the safety profile and tolerability of...
Show More Location
Multiple Locations
Learn More & Join Trial
A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL N/A This is a prospective, observational, multicenter, cohort study with 400 ne...
Show More Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai
Learn More & Join Trial
Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma PHASE3 B-cell non-Hodgkin's lymphoma (B-NHL) is the most common type of NHL. Altho...
Show More Location
Shandong Provincial Hospital
Learn More & Join Trial
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas PHASE2 This phase II/III trial tests whether it is possible to decrease the chance...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial